EQS-DD: Viromed Medical AG: Uwe Perbandt, buy

19.11.24 17:00 Uhr

Werte in diesem Artikel




Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

19.11.2024 / 17:00 CET/CEST
The issuer is solely responsible for the content of this announcement.








1. Details of the person discharging managerial responsibilities / person closely associated

a) Name




Title:
First name: Uwe
Last name(s): Perbandt

2. Reason for the notification

a) Position / status




Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Viromed Medical AG

b) LEI
894500XR05MYCVCCR171 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code




Type: Share
ISIN: DE000A3MQR65

b) Nature of the transaction


Acquisition

c) Price(s) and volume(s)














Price(s) Volume(s)
2.3000 EUR 3450.0000 EUR
2.2800 EUR 13680.0000 EUR
2.2400 EUR 6899.2000 EUR
2.2000 EUR 2046.0000 EUR
2.2000 EUR 2200.0000 EUR
1.9600 EUR 997.6400 EUR

d) Aggregated information




Price Aggregated volume
2.2485 EUR 29272.8400 EUR

e) Date of the transaction
15/11/2024; UTC+1

f) Place of the transaction




Name: Xetra
MIC: XETR



19.11.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
















Language: English
Company: Viromed Medical AG
Flensburger Straße 18
25421 Pinneberg
Germany
Internet: https://www.viromed-medical-ag.de/



 
End of News EQS News Service





95405  19.11.2024 CET/CEST





Ausgewählte Hebelprodukte auf Fonterelli SPAC 2

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Fonterelli SPAC 2

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Fonterelli SPAC 2 AG Inhaber-Akt